GB8524135D0 - Darodipine compositions - Google Patents
Darodipine compositionsInfo
- Publication number
- GB8524135D0 GB8524135D0 GB858524135A GB8524135A GB8524135D0 GB 8524135 D0 GB8524135 D0 GB 8524135D0 GB 858524135 A GB858524135 A GB 858524135A GB 8524135 A GB8524135 A GB 8524135A GB 8524135 D0 GB8524135 D0 GB 8524135D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- darodipine
- compositions
- darodipine compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (29)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858524135A GB8524135D0 (en) | 1985-10-01 | 1985-10-01 | Darodipine compositions |
NL8602370A NL194822C (en) | 1985-10-01 | 1986-09-19 | Preparation for oral administration with controlled release and method for its preparation. |
HU864004A HU197201B (en) | 1985-10-01 | 1986-09-19 | Process for producing oral pharmaceutical compositions of controlled solubility of the active components |
CH3780/86A CH669524A5 (en) | 1985-10-01 | 1986-09-22 | |
DE3632201A DE3632201C2 (en) | 1985-10-01 | 1986-09-23 | Pharmaceutical composition with sustained release of the active substance |
PT83456A PT83456B (en) | 1985-10-01 | 1986-09-29 | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS OF CONTROLLED LIBERTACAOUS ACTIVE SUBSTANCE |
GR862457A GR862457B (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical formulations with controlled release of the active substance |
DK464686A DK170016B1 (en) | 1985-10-01 | 1986-09-29 | Composition with controlled release of the active substance |
CA000519302A CA1298784C (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical formulations with controlled release of the active substance |
KR1019860008136A KR920008817B1 (en) | 1985-10-01 | 1986-09-29 | Process for the preparing pharmaceutical formulations with controlled release of the active substance |
IL80182A IL80182A (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical formulations containing darodipine or isradipine with controlled release of the active substance |
NZ217732A NZ217732A (en) | 1985-10-01 | 1986-09-29 | Controlled release formulation for oral administration which includes either pindolol or a 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester |
AU63226/86A AU598751B2 (en) | 1985-02-07 | 1986-09-29 | Pharmaceutical formulations with controlled release of the active substance |
GB8623389A GB2181053B (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical formulations with controlled release of the active substance |
SE8604112A SE503222C2 (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical preparations with controlled release of isradipine or darodipine |
IE256586A IE59589B1 (en) | 1985-10-01 | 1986-09-29 | Pharmaceutical formulations with controlled release of the active substance |
BE1/011554A BE905516A (en) | 1985-10-01 | 1986-09-30 | NEW EXTENDED RELEASE FORMULATION. |
LU86615A LU86615A1 (en) | 1985-10-01 | 1986-09-30 | NEW EXTENDED RELEASE FORMULATION |
JP23424986A JPS62149618A (en) | 1985-10-01 | 1986-09-30 | Active substance release control medicine |
AT0260486A AT402257B (en) | 1985-10-01 | 1986-09-30 | METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF A 4- (2,1,3-BENZOXADIAZOL-4-YL) -1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINE DICARBOXYLATE ESTER ACTIVE SUBSTANCE |
ES8602313A ES2002508A6 (en) | 1985-10-01 | 1986-09-30 | New sustained-release formulation based on pindolol |
IT8648494A IT1214719B (en) | 1985-10-01 | 1986-09-30 | Controlled release cardiovascular preparations |
FR868613668A FR2589732B1 (en) | 1985-10-01 | 1986-10-01 | NEW EXTENDED RELEASE FORMULATION BASED ON PINDOLOL |
ZA877507A ZA867507B (en) | 1985-10-01 | 1986-10-01 | Pharmaceutical formulations with controlled release of the active substance |
AU53020/90A AU626404B2 (en) | 1985-10-01 | 1990-04-09 | A controlled release formulation of 4-(2,1,3-benzoxadizaol-4 -yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridine dicarboxylate ester |
SG1033/91A SG103391G (en) | 1985-10-01 | 1991-12-04 | Pharmaceutical formulations with controlled release of the active substance |
HK3/92A HK392A (en) | 1985-10-01 | 1992-01-02 | Pharmaceutical formulations with controlled release of the active substance |
MX9203614A MX9203614A (en) | 1985-10-01 | 1992-06-26 | PHARMACEUTICAL FORMULATION OF CONTROLLED RELEASE FOR ORAL ADMINISTRATION. |
CY1622A CY1622A (en) | 1985-10-01 | 1992-07-10 | Pharmaceutical formulations with controlled release of the active substance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858524135A GB8524135D0 (en) | 1985-10-01 | 1985-10-01 | Darodipine compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB8524135D0 true GB8524135D0 (en) | 1985-11-06 |
Family
ID=10585981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB858524135A Pending GB8524135D0 (en) | 1985-02-07 | 1985-10-01 | Darodipine compositions |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS62149618A (en) |
AU (1) | AU626404B2 (en) |
GB (1) | GB8524135D0 (en) |
ZA (1) | ZA867507B (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH630257A5 (en) * | 1975-03-17 | 1982-06-15 | Hoffmann La Roche | Sustained release formulation |
DE3045135A1 (en) * | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | BODEGRADABLE POLYMERS CONTAINING PHARMACEUTICAL COMPOSITIONS |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
IT1174779B (en) * | 1982-09-27 | 1987-07-01 | Sandoz Ag | THERAPEUTIC USE OF 1,4-DI HYDROPYRIDINE DERIVATIVES |
JPS60202912A (en) * | 1984-03-28 | 1985-10-14 | Hitachi Metals Ltd | Manufacture of anisotropic magnet roll |
-
1985
- 1985-10-01 GB GB858524135A patent/GB8524135D0/en active Pending
-
1986
- 1986-09-30 JP JP23424986A patent/JPS62149618A/en active Pending
- 1986-10-01 ZA ZA877507A patent/ZA867507B/en unknown
-
1990
- 1990-04-09 AU AU53020/90A patent/AU626404B2/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
JPS62149618A (en) | 1987-07-03 |
AU5302090A (en) | 1990-08-09 |
AU626404B2 (en) | 1992-07-30 |
ZA867507B (en) | 1988-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL78934A (en) | Alfuzosine compositions | |
GB8514052D0 (en) | Compositions | |
MW5186A1 (en) | Compositions | |
GB2174904B (en) | Vasculoprotecting pharmaceutical compositions | |
GB8509409D0 (en) | Compositions | |
GB2171600B (en) | Pharmaceutical compositions | |
EP0197752A3 (en) | Pharmaceutical compositions | |
GR860123B (en) | Compositions | |
EP0192630A3 (en) | Aminomethylenephosphonate compositions | |
GB2182561B (en) | Pharmaceutical compositions | |
GB8513550D0 (en) | Compositions | |
EP0225309A3 (en) | Aminomethylenephosphonate compositions | |
GB8520289D0 (en) | Compositions | |
ZA86355B (en) | Compositions | |
GB8603048D0 (en) | Lymphokine-containing compositions | |
GB8502887D0 (en) | Pharmaceutical compositions | |
GB8524135D0 (en) | Darodipine compositions | |
EG17458A (en) | Fungicial compositions | |
GB8514860D0 (en) | Compositions | |
GB8518581D0 (en) | Compositions | |
GB8527416D0 (en) | Compositions | |
GB8617065D0 (en) | Compositions | |
GB8527406D0 (en) | Compositions | |
GB8526500D0 (en) | Compositions | |
GB8526499D0 (en) | Compositions |